Treatment of refractory dissecting cellulitis of the scalp with guselkumab: Case report
Authors:
Open Access
- 1 January 2020
- journal article
- case report
- Published by Medknow in Journal of Dermatology and Dermatologic Surgery
- Vol. 24 (1) , 52-53
Abstract
Dissecting cellulitis (DC) of the scalp is a chronic, clinically refractory inflammatory skin disorder. Herein is a presentation of a male with refractory DC with concurrent hidradenitis suppurativa, who had failed treatment with multiple topical and systemic therapies. After receiving guselkumab, 100 mg subcutaneously every 8 weeks, the patient exhibited marked improvement, with normalization of symptoms and signs.Keywords
This publication has 4 references indexed in Scilit:
- Guselkumab in the treatment of hidradenitis suppurativa: A retrospective chart reviewJournal of the American Academy of Dermatology, 2019
- Biologics in patients with skin diseasesJournal of Allergy and Clinical Immunology, 2017
- Dissecting cellulitis of the scalp: a retrospective study of 51 patients and review of literatureBritish Journal of Dermatology, 2015
- Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativaJournal of the American Academy of Dermatology, 2011